Physician profile
Michael J Kellis
NPI 1831190313
$641.18
in general payments reported to CMS, 2019-2025
13 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.87 · 2021: $21.30 · 2022: $55.79 · 2023: $16.02 · 2024: $329 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $144.10 | 2022-2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Ferring Pharmaceuticals INC. | $108.19 | 2022-2025 | Euflexxa |
| Averitas Pharma INC. | $84.60 | 2024 | Qutenza |
| Vericel Corporation | $49.34 | 2019-2023 | Maci |
| Nevro Corp. | $48.18 | 2024 | Senza |
| Ethicon US, LLC | $44.09 | 2024 | Surgicel Nu-Knit |
| Pacira Therapeutics, INC. | $40.67 | 2019-2021 | |
| Abbvie INC. | $30.53 | 2025 | |
| Moximed, INC | $29.44 | 2025 | Misha Knee System, Small, Left |
| Triad Life Sciences INC. | $23.21 | 2022 | |
| Solventum Corporation | $15.65 | 2025 | Promogran Prisma, Prevena, V.A.C. Veraflo |
| Integra Lifesciences Corporation | $15.17 | 2019 | |
| Orthofix Medical, INC. | $8.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.